Brief: N4 Pharma Shareholders Pass Resolution To Change Co Name To Thalia Therapeutics
17/03/2026 13:31
March 17 (Reuters) - N4 Pharma PLC N4P.L: N4 PHARMA PLC - SPECIAL RESOLUTION TO CHANGE NAME TO THALIA THERAPEUTICS PLC PASSED Source text: ID:nRSQ9980Wa Further company coverage: N4P.L ((Reuters.Briefs@thomsonreuters.com))
Recent news on Thalia Therapeutics
See all newsThalia Therapeutics - Interim Results
Brief: Thalia Therapeutics Says New Patent Granted For Miristen In China
Thalia Therapeutics - New Patent Granted for miRisten in China
Thalia Therapeutics - RNA gene-silencing cardiovascular program advances
Thalia Therapeutics - Business Update and Notice of Results